275 related articles for article (PubMed ID: 34884800)
1. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
Angenoorth TJF; Stankovic S; Niello M; Holy M; Brandt SD; Sitte HH; Maier J
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884800
[TBL] [Abstract][Full Text] [Related]
2. α-PPP and its derivatives are selective partial releasers at the human norepinephrine transporter: A pharmacological characterization of interactions between pyrrolidinopropiophenones and high and low affinity monoamine transporters.
Maier J; Rauter L; Rudin D; Niello M; Holy M; Schmid D; Wilson J; Blough BE; Gannon BM; Murnane KS; Sitte HH
Neuropharmacology; 2021 Jun; 190():108570. PubMed ID: 33864800
[TBL] [Abstract][Full Text] [Related]
3. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3.
Duan H; Wang J
J Pharmacol Exp Ther; 2010 Dec; 335(3):743-53. PubMed ID: 20858707
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of novel decynium-22 analogs to inhibit transport by the low-affinity, high-capacity monoamine transporters, organic cation transporters 2 and 3, and plasma membrane monoamine transporter.
Fraser-Spears R; Krause-Heuer AM; Basiouny M; Mayer FP; Manishimwe R; Wyatt NA; Dobrowolski JC; Roberts MP; Greguric I; Kumar N; Koek W; Sitte HH; Callaghan PD; Fraser BH; Daws LC
Eur J Pharmacol; 2019 Jan; 842():351-364. PubMed ID: 30473490
[TBL] [Abstract][Full Text] [Related]
5. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
Pifl C; Reither H; Hornykiewicz O
Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
[TBL] [Abstract][Full Text] [Related]
6. Interaction of antidepressant and antipsychotic drugs with the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Haenisch B; Drescher E; Thiemer L; Xin H; Giros B; Gautron S; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2012 Oct; 385(10):1017-23. PubMed ID: 22806583
[TBL] [Abstract][Full Text] [Related]
7. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3.
Hayer-Zillgen M; Brüss M; Bönisch H
Br J Pharmacol; 2002 Jul; 136(6):829-36. PubMed ID: 12110607
[TBL] [Abstract][Full Text] [Related]
8. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
Brandt SD; Walters HM; Partilla JS; Blough BE; Kavanagh PV; Baumann MH
Psychopharmacology (Berl); 2020 Dec; 237(12):3703-3714. PubMed ID: 32875347
[TBL] [Abstract][Full Text] [Related]
9. Potent and Selective Inhibition of Plasma Membrane Monoamine Transporter by HIV Protease Inhibitors.
Duan H; Hu T; Foti RS; Pan Y; Swaan PW; Wang J
Drug Metab Dispos; 2015 Nov; 43(11):1773-80. PubMed ID: 26285765
[TBL] [Abstract][Full Text] [Related]
10. Substrates and Inhibitors of Organic Cation Transporters (OCTs) and Plasma Membrane Monoamine Transporter (PMAT) and Therapeutic Implications.
Bönisch H
Handb Exp Pharmacol; 2021; 266():119-167. PubMed ID: 34495395
[TBL] [Abstract][Full Text] [Related]
11. The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2.
Jouan E; Le Vee M; Denizot C; Da Violante G; Fardel O
Fundam Clin Pharmacol; 2014 Feb; 28(1):65-77. PubMed ID: 22913740
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs.
Han DD; Gu HH
BMC Pharmacol; 2006 Mar; 6():6. PubMed ID: 16515684
[TBL] [Abstract][Full Text] [Related]
13. Overlap and Specificity in the Substrate Spectra of Human Monoamine Transporters and Organic Cation Transporters 1, 2, and 3.
Gebauer L; Jensen O; Neif M; Brockmöller J; Dücker C
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884618
[TBL] [Abstract][Full Text] [Related]
14. Interaction of the human plasma membrane monoamine transporter (hPMAT) with antidepressants and antipsychotics.
Haenisch B; Bönisch H
Naunyn Schmiedebergs Arch Pharmacol; 2010 Jan; 381(1):33-9. PubMed ID: 20012264
[TBL] [Abstract][Full Text] [Related]
15. Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene.
Duan H; Wang J
J Biol Chem; 2013 Feb; 288(5):3535-44. PubMed ID: 23255610
[TBL] [Abstract][Full Text] [Related]
16. Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family.
Mayer FP; Burchardt NV; Decker AM; Partilla JS; Li Y; McLaughlin G; Kavanagh PV; Sandtner W; Blough BE; Brandt SD; Baumann MH; Sitte HH
Neuropharmacology; 2018 May; 134(Pt A):149-157. PubMed ID: 28988906
[TBL] [Abstract][Full Text] [Related]
17. 2-Aminoindan and its ring-substituted derivatives interact with plasma membrane monoamine transporters and α
Halberstadt AL; Brandt SD; Walther D; Baumann MH
Psychopharmacology (Berl); 2019 Mar; 236(3):989-999. PubMed ID: 30904940
[TBL] [Abstract][Full Text] [Related]
18. The psychostimulant (±)-cis-4,4'-dimethylaminorex (4,4'-DMAR) interacts with human plasmalemmal and vesicular monoamine transporters.
Maier J; Mayer FP; Luethi D; Holy M; Jäntsch K; Reither H; Hirtler L; Hoener MC; Liechti ME; Pifl C; Brandt SD; Sitte HH
Neuropharmacology; 2018 Aug; 138():282-291. PubMed ID: 29908239
[TBL] [Abstract][Full Text] [Related]
19. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
Verrico CD; Miller GM; Madras BK
Psychopharmacology (Berl); 2007 Jan; 189(4):489-503. PubMed ID: 16220332
[TBL] [Abstract][Full Text] [Related]
20. High affinity of 4-(4-(dimethylamino)styryl)-N-methylpyridinium transport for assessing organic cation drugs in hepatocellular carcinoma cells.
Jinakote M; Ontawong A; Soodvilai S; Pimta J; Pasachan T; Chatsudthipong V; Srimaroeng C
Fundam Clin Pharmacol; 2020 Jun; 34(3):365-379. PubMed ID: 31883148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
